 Todd Getz
Concepts (168)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood Platelets | 18 | 2022 | 351 | 3.900 |
Why?
| | Blood Preservation | 7 | 2022 | 263 | 1.720 |
Why?
| | Cryopreservation | 3 | 2022 | 92 | 1.130 |
Why?
| | Platelet Aggregation | 6 | 2020 | 94 | 1.100 |
Why?
| | Intracellular Signaling Peptides and Proteins | 3 | 2013 | 386 | 0.740 |
Why?
| | Hemostasis | 5 | 2023 | 67 | 0.730 |
Why?
| | Protein-Tyrosine Kinases | 3 | 2013 | 395 | 0.700 |
Why?
| | Suntan | 1 | 2019 | 1 | 0.660 |
Why?
| | Platelet Transfusion | 2 | 2020 | 64 | 0.650 |
Why?
| | Platelet Membrane Glycoproteins | 5 | 2013 | 39 | 0.610 |
Why?
| | Bleeding Time | 2 | 2015 | 6 | 0.510 |
Why?
| | Saphenous Vein | 2 | 2015 | 31 | 0.510 |
Why?
| | Receptors, Thrombin | 2 | 2013 | 11 | 0.460 |
Why?
| | Vascular System Injuries | 1 | 2015 | 66 | 0.450 |
Why?
| | Dextran Sulfate | 1 | 2013 | 70 | 0.420 |
Why?
| | Blood Coagulation | 4 | 2019 | 218 | 0.420 |
Why?
| | Threonine | 2 | 2010 | 40 | 0.380 |
Why?
| | Flow Cytometry | 5 | 2019 | 1083 | 0.380 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2013 | 329 | 0.370 |
Why?
| | Blood Component Removal | 2 | 2022 | 29 | 0.370 |
Why?
| | Myosin Light Chains | 1 | 2010 | 26 | 0.360 |
Why?
| | Carbazoles | 1 | 2011 | 78 | 0.360 |
Why?
| | Plateletpheresis | 3 | 2022 | 25 | 0.350 |
Why?
| | Serine | 1 | 2010 | 126 | 0.340 |
Why?
| | Apoptosis | 1 | 2019 | 2362 | 0.340 |
Why?
| | Platelet Activation | 6 | 2015 | 68 | 0.290 |
Why?
| | Cold Temperature | 2 | 2020 | 126 | 0.290 |
Why?
| | Thromboplastin | 2 | 2015 | 71 | 0.240 |
Why?
| | Reactive Oxygen Species | 2 | 2019 | 531 | 0.240 |
Why?
| | Lectins, C-Type | 3 | 2013 | 61 | 0.220 |
Why?
| | Syk Kinase | 3 | 2013 | 18 | 0.220 |
Why?
| | Thrombosis | 2 | 2015 | 298 | 0.190 |
Why?
| | Mice, Knockout | 7 | 2018 | 2565 | 0.180 |
Why?
| | Shock, Hemorrhagic | 1 | 2023 | 199 | 0.180 |
Why?
| | Ticlopidine | 3 | 2015 | 55 | 0.180 |
Why?
| | Quinolines | 1 | 2020 | 129 | 0.170 |
Why?
| | Isoenzymes | 2 | 2011 | 283 | 0.160 |
Why?
| | Platelet Count | 1 | 2019 | 81 | 0.160 |
Why?
| | Factor IX | 2 | 2018 | 34 | 0.160 |
Why?
| | Hemostatics | 1 | 2019 | 47 | 0.160 |
Why?
| | Protein Kinase C | 2 | 2011 | 273 | 0.150 |
Why?
| | Protein S | 1 | 2018 | 5 | 0.150 |
Why?
| | Factor IXa | 1 | 2018 | 16 | 0.150 |
Why?
| | Hemophilia B | 1 | 2018 | 36 | 0.150 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2019 | 511 | 0.150 |
Why?
| | Calcium | 3 | 2013 | 1104 | 0.150 |
Why?
| | Lactic Acid | 1 | 2019 | 275 | 0.140 |
Why?
| | Platelet Aggregation Inhibitors | 3 | 2015 | 401 | 0.140 |
Why?
| | Heparin | 1 | 2018 | 224 | 0.140 |
Why?
| | Humans | 20 | 2023 | 114616 | 0.130 |
Why?
| | Venous Thrombosis | 1 | 2018 | 140 | 0.130 |
Why?
| | Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2016 | 22 | 0.130 |
Why?
| | Refrigeration | 1 | 2016 | 11 | 0.130 |
Why?
| | Emergency Medical Services | 1 | 2023 | 590 | 0.130 |
Why?
| | Mice, Inbred C57BL | 5 | 2018 | 4689 | 0.130 |
Why?
| | Solutions | 1 | 2016 | 146 | 0.130 |
Why?
| | Wounds and Injuries | 1 | 2023 | 745 | 0.130 |
Why?
| | rap1 GTP-Binding Proteins | 1 | 2015 | 4 | 0.120 |
Why?
| | Platelet Glycoprotein GPIb-IX Complex | 1 | 2015 | 3 | 0.120 |
Why?
| | Talin | 1 | 2015 | 7 | 0.120 |
Why?
| | Platelet Adhesiveness | 1 | 2015 | 14 | 0.120 |
Why?
| | Microscopy, Video | 1 | 2015 | 26 | 0.120 |
Why?
| | Cell-Derived Microparticles | 1 | 2015 | 57 | 0.120 |
Why?
| | Intravital Microscopy | 1 | 2015 | 23 | 0.120 |
Why?
| | GTPase-Activating Proteins | 1 | 2015 | 71 | 0.120 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2019 | 1842 | 0.120 |
Why?
| | Skin | 1 | 2019 | 655 | 0.120 |
Why?
| | Fibrinogens, Abnormal | 1 | 2014 | 4 | 0.120 |
Why?
| | Fibrin | 1 | 2015 | 65 | 0.120 |
Why?
| | Mitochondria | 2 | 2019 | 747 | 0.120 |
Why?
| | Phosphorylation | 4 | 2013 | 1569 | 0.120 |
Why?
| | Glucose | 1 | 2019 | 896 | 0.110 |
Why?
| | Peptides, Cyclic | 2 | 2013 | 253 | 0.110 |
Why?
| | Signal Transduction | 5 | 2013 | 4509 | 0.110 |
Why?
| | Laser Therapy | 1 | 2015 | 100 | 0.110 |
Why?
| | Crotalid Venoms | 2 | 2011 | 31 | 0.110 |
Why?
| | Fibrinogen | 1 | 2014 | 154 | 0.110 |
Why?
| | Animals | 11 | 2018 | 31692 | 0.110 |
Why?
| | Microscopy, Fluorescence | 1 | 2015 | 396 | 0.110 |
Why?
| | Bacteria | 1 | 2019 | 725 | 0.110 |
Why?
| | Polysaccharides | 1 | 2013 | 78 | 0.100 |
Why?
| | Mice | 9 | 2015 | 14859 | 0.100 |
Why?
| | Arteries | 1 | 2014 | 247 | 0.100 |
Why?
| | Tyrosine | 1 | 2013 | 214 | 0.100 |
Why?
| | Protein Binding | 2 | 2018 | 1888 | 0.100 |
Why?
| | Time Factors | 3 | 2020 | 6112 | 0.100 |
Why?
| | Cells, Cultured | 1 | 2019 | 3881 | 0.090 |
Why?
| | Blood Vessels | 1 | 2013 | 180 | 0.090 |
Why?
| | Peptides | 3 | 2011 | 848 | 0.090 |
Why?
| | Energy Metabolism | 1 | 2016 | 731 | 0.090 |
Why?
| | Membrane Glycoproteins | 1 | 2013 | 430 | 0.090 |
Why?
| | Cell Shape | 1 | 2010 | 54 | 0.090 |
Why?
| | Adenosine Diphosphate | 1 | 2010 | 81 | 0.090 |
Why?
| | Kinetics | 2 | 2010 | 1551 | 0.090 |
Why?
| | rho-Associated Kinases | 1 | 2010 | 80 | 0.090 |
Why?
| | Amino Acids, Aromatic | 1 | 2009 | 7 | 0.080 |
Why?
| | Carrier Proteins | 2 | 2011 | 695 | 0.080 |
Why?
| | Collagen Type IV | 1 | 2009 | 22 | 0.080 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 2010 | 147 | 0.080 |
Why?
| | Disease Models, Animal | 2 | 2018 | 3531 | 0.080 |
Why?
| | Calcium Signaling | 1 | 2011 | 213 | 0.080 |
Why?
| | In Vitro Techniques | 1 | 2011 | 1016 | 0.080 |
Why?
| | Protein Structure, Secondary | 1 | 2009 | 325 | 0.080 |
Why?
| | Protein Kinase C-delta | 1 | 2009 | 70 | 0.080 |
Why?
| | Inflammation | 2 | 2014 | 2477 | 0.060 |
Why?
| | Protein Kinase Inhibitors | 1 | 2011 | 785 | 0.060 |
Why?
| | Thrombin | 2 | 2015 | 139 | 0.060 |
Why?
| | Warfare | 1 | 2023 | 75 | 0.050 |
Why?
| | Thrombocytopenia | 2 | 2015 | 177 | 0.050 |
Why?
| | Benzothiazoles | 1 | 2020 | 32 | 0.040 |
Why?
| | Resuscitation | 1 | 2023 | 252 | 0.040 |
Why?
| | Plasma | 1 | 2022 | 211 | 0.040 |
Why?
| | Freeze Drying | 1 | 2019 | 75 | 0.040 |
Why?
| | Hemorrhage | 1 | 2023 | 620 | 0.040 |
Why?
| | Male | 5 | 2018 | 55549 | 0.040 |
Why?
| | Coagulants | 1 | 2018 | 12 | 0.040 |
Why?
| | Binding, Competitive | 1 | 2018 | 193 | 0.040 |
Why?
| | Thrombelastography | 1 | 2019 | 180 | 0.040 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2018 | 129 | 0.040 |
Why?
| | Infusions, Intravenous | 1 | 2018 | 371 | 0.030 |
Why?
| | Oxygen Consumption | 1 | 2019 | 588 | 0.030 |
Why?
| | Female | 4 | 2016 | 59461 | 0.030 |
Why?
| | Thrombopoiesis | 1 | 2015 | 6 | 0.030 |
Why?
| | Receptors, Purinergic P2Y12 | 1 | 2015 | 6 | 0.030 |
Why?
| | Lymphopenia | 1 | 2015 | 49 | 0.030 |
Why?
| | Splenectomy | 1 | 2015 | 52 | 0.030 |
Why?
| | Guanine Nucleotide Exchange Factors | 1 | 2015 | 55 | 0.030 |
Why?
| | Binding Sites | 1 | 2018 | 1168 | 0.030 |
Why?
| | Blood Coagulation Tests | 1 | 2014 | 57 | 0.030 |
Why?
| | Antithrombins | 1 | 2014 | 49 | 0.030 |
Why?
| | Cellular Senescence | 1 | 2015 | 152 | 0.030 |
Why?
| | Pulmonary Embolism | 1 | 2015 | 181 | 0.030 |
Why?
| | Protein Isoforms | 1 | 2014 | 338 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2015 | 398 | 0.030 |
Why?
| | Cell Survival | 1 | 2016 | 1020 | 0.030 |
Why?
| | Immunoprecipitation | 1 | 2013 | 151 | 0.030 |
Why?
| | Adoptive Transfer | 1 | 2013 | 195 | 0.030 |
Why?
| | src-Family Kinases | 1 | 2013 | 88 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2015 | 1143 | 0.030 |
Why?
| | Hemophilia A | 1 | 2013 | 69 | 0.020 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2013 | 194 | 0.020 |
Why?
| | Receptor Protein-Tyrosine Kinases | 1 | 2013 | 226 | 0.020 |
Why?
| | Phosphoproteins | 1 | 2013 | 298 | 0.020 |
Why?
| | Phospholipase C gamma | 1 | 2010 | 26 | 0.020 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2013 | 367 | 0.020 |
Why?
| | Gene Knockout Techniques | 1 | 2010 | 98 | 0.020 |
Why?
| | Phenylalanine | 1 | 2009 | 57 | 0.020 |
Why?
| | Adenocarcinoma | 1 | 2015 | 795 | 0.020 |
Why?
| | Thromboxane A2 | 1 | 2009 | 11 | 0.020 |
Why?
| | Receptors, Proteinase-Activated | 1 | 2009 | 1 | 0.020 |
Why?
| | Protein Kinase C-theta | 1 | 2009 | 3 | 0.020 |
Why?
| | Qa-SNARE Proteins | 1 | 2009 | 13 | 0.020 |
Why?
| | Crystallization | 1 | 2009 | 136 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2015 | 2710 | 0.020 |
Why?
| | Solubility | 1 | 2009 | 223 | 0.020 |
Why?
| | Pancreatic Neoplasms | 1 | 2015 | 731 | 0.020 |
Why?
| | Anticoagulants | 1 | 2013 | 550 | 0.020 |
Why?
| | Crystallography, X-Ray | 1 | 2009 | 402 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2013 | 1947 | 0.020 |
Why?
| | Mutation | 1 | 2018 | 3344 | 0.020 |
Why?
| | Oligopeptides | 1 | 2009 | 236 | 0.020 |
Why?
| | Antibodies | 1 | 2009 | 371 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2009 | 1982 | 0.020 |
Why?
| | Gene Expression | 1 | 2010 | 1421 | 0.020 |
Why?
| | Peptide Fragments | 1 | 2009 | 665 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2009 | 2785 | 0.010 |
Why?
| | Neoplasms | 1 | 2015 | 2097 | 0.010 |
Why?
| | Middle Aged | 1 | 2014 | 26719 | 0.010 |
Why?
|
|
Getz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|